deaths from glp-1 Millions of Americans have turned to compounded medications, including versions of Ozempic and Wegovy. But are they safe? Stanford Medicine clinicians explain the safety concerns, and what to do if you're Cardiovascular and mortality outcomes with

Compounded medications are real medications

Laboratory studies have demonstrated that GLP-1 receptor activation can reduce the production of pro-inflammatory cytokines, including tumour necrosis factor-alpha (TNF-), interleukin-6 (IL-6), and interleukin-1 beta (IL-1)

F1000Research, 9, F1000 Faculty Rev-239

Individuals who smoked cigarettes showed significantly greater reductions in cigarettes per day when receiving semaglutide compared to the placebo group 22

Medicare Obesity Coverage Expansion (Regulatory): The Centers for Medicare & Medicaid Services (CMS) announced that beginning in April 2026, Medicare will cover GLP-1 medications for beneficiaries with obesity and qualifying comorbidities via the BALANCE Model and Section 402 demonstrations, marking a reversal of the long-standing statutory ban on weight-loss drug coverage